MedCity & NHSA UK Delegation to Japan
Posted on
MedCity and the Northern Health Science Alliance are heading to Korea and Japan this October, including the annual biotech partnering conference, BioJapan, and are inviting UK life sciences companies and scientific academics to join the mission.
MedCity have led several life sciences and healthcare delegations to Japan over the past few years and have extensive connections to the major industry and academic associations; including Japan Bioindustries Association (JBA), Japan Health Sciences Foundation (JHSF), LINK-J and The Forum for Innovative Regenerative Medicine (FIRM).
They are looking for innovative companies who want to expand into the Japanese market and researchers looking for collaborative opportunities, to join this high-profile delegation.
For more information and to register your interest in attending please visit http://www.medcityhq.com/2018/04/27/join-medcity-nhsa-uk-delegation-to-japan/.
Related content
DigitalHealth.London Spotlight: CyberLiver
Every week, we shine a spotlight on one of our DigitalHealth.London companies, founders, or NHS fellows. Today, to commemorate World Liver Day, we are excited to feature our current DigitalHealth.London Accelerator company CyberLiver.
Bridging Gaps in Women’s Health: The Rise of FemTech Innovation
As innovations in FemTech continue to evolve, the future of women’s health holds promise for improved equity and accessibility. In this blog, Lavinia Pamparau, NHS Navigator for DigitalHealth.London, delves into how FemTech solutions tackle prevailing health disparities and empower women to proactively manage their health and well-being.
Getting FemTech into the NHS
FemTech has the potential to tackle health inequalities related to gender and improve the quality of life for millions of women in the UK. But, to achieve maximum impact, FemTech needs to be fully integrated into NHS pathways and services. In this blog, NHS Navigator for DigitalHealth.London Yasmin Stinchcombe explores how FemTech innovators can successfully engage with the NHS.
